Aluminum Oxide Nanoparticles as Carriers and Adjuvants for Eliciting Antibodies from Non-immunogenic Haptens

被引:26
|
作者
Maquieira, Angel [1 ]
Brun, Eva M. [1 ]
Garces-Garcia, Marta [1 ]
Puchades, Rosa [1 ]
机构
[1] Univ Politecn Valencia, Dept Quim, Ctr Reconocimiento Mol & Desarrollo Tecnol, Valencia 46022, Spain
关键词
VACCINE; RECOGNITION; SURFACE; IMMUNIZATION; GOLD;
D O I
10.1021/ac3020998
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Functionalized nanomaterials have applications yet to be discovered, especially in the biological field and, in particular, the in vivo production of antibodies. In this paper, we show that aluminum oxide nanoparticles that are covalently coupled to haptens (small molecular mass compounds) activate the immune system, eliciting antibodies (polyclonal and monoclonal) specific for the herbicide atrazine, the. antibiotic sulfasalazine, and the vitamin biotin in mice and rabbits. The particles play the role of carrier and adjuvant, with the immune response being dependent on size and crystallinity. The affinity constants of the antibodies are similar to those reached with traditional immunization strategies based on the use of carrier proteins. This approach has not been previously described, being of scientific and practical interest, as it can lead to immunogens safer than the conventional ones, potentially applicable to human vaccination. In addition, the useful advantages of this technique include the stability of the metallic particles, the synthesis of immunogens in organic media, the versatility of particle derivatization, the ease of purification, the full chemical characterization of immunogens, the lack of a requirement for an adjuvant, the reduction of the cross reactivity, and the low cost of materials. Also, the analytical performances of the immunoassays developed using these antibodies are comparable to those obtained by the standard protocols. Analytical applications of the developed ELISAs were fully demonstrated. Characterization (IgG nature, affinity constants, etc.) of the immunoreagents were also fully assessed.
引用
收藏
页码:9340 / 9348
页数:9
相关论文
共 50 条
  • [1] Arthritis induced in rats with non-immunogenic adjuvants as models for rheumatoid arthritis
    Holmdahl, R
    Lorentzen, JC
    Lu, SM
    Olofsson, P
    Wester, L
    Holmberg, J
    Pettersson, U
    IMMUNOLOGICAL REVIEWS, 2001, 184 : 184 - 202
  • [2] IMMUNE RESPONSE IN GUINEA PIGS TO CONJUGATES OF A STEROID HAPTEN WITH IMMUNOGENIC AND NON-IMMUNOGENIC CARRIERS
    PINTO, M
    RIMON, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1970, 38 (05): : 527 - &
  • [3] Silver nanoparticles induce a non-immunogenic tumor cell death
    Garcia Garcia, Maritza Roxana
    Casares, Noelia
    Martinez Perez, Luz Andrea
    Juarez Curiel, Efren
    de Jesus Hernandez, Andres Alberto
    Bogdanchikova, Nina
    Garibo, Diana
    Rodriguez-Hernandez, Ana G.
    Pestryakov, Alexey
    Castro Gamboa, Sandra
    Arias Ruiz, Luis Felipe
    Torres Bugarin, Olivia
    Berraondo, Pedro
    JOURNAL OF IMMUNOTOXICOLOGY, 2023, 20 (01)
  • [4] Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
    Vyas, SP
    Sihorkar, V
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 43 (2-3) : 101 - 164
  • [5] Tapasin domain 1-a tool to discriminate immunogenic from non-immunogenic peptides
    Geironson, Linda
    Roeder, Gustav
    Thuring, Camilla
    Rasmussen, Michael
    Harndahl, Mikkel
    Paulsson, Kajsa
    MOLECULAR IMMUNOLOGY, 2012, 51 (01) : 15 - 15
  • [6] Non-immunogenic polymeric nanoparticles as an efficient brain-blood barrier targeting agent
    Ferrao, R.
    Rai, A.
    Ferreira, L. S.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52
  • [7] DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coli
    Ruth, N
    Mainil, J
    Roupie, V
    Frère, JM
    Galleni, M
    Huygen, K
    VACCINE, 2005, 23 (27) : 3618 - 3627
  • [8] Non-immunogenic polymeric nanoparticles as an efficient brain-blood barrier targeting agent
    Ferrao, R.
    Rai, A.
    Ferreira, L. S.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52
  • [9] ISOLATION OF IMMUNOGENIC ENTITIES FROM NON-IMMUNOGENIC TRANSPLANTABLE TUMORS AND THEIR NORMAL-CELL COUNTERPARTS
    KLEIN, BY
    SHARON, R
    AVRAHAM, Y
    AHITUV, A
    NAOR, D
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (01) : 225 - 231
  • [10] IMMUNOGENIC NEOPLASTIC CLONES DERIVED INVITRO FROM AN ORIGINALLY NON-IMMUNOGENIC BALB-C FIBROSARCOMA
    CARBONE, G
    PARMIANI, G
    TUMORI, 1977, 63 (06) : 513 - 518